Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

The treatment increased total hair count but wasn't significantly better than placebo.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Azathioprine may be an effective treatment for severe hair loss.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Mycophenolate helps reverse hair loss effects caused by IFN-γ by activating a key hair growth pathway.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

The new human placental extract may help prevent hair graying and reduce nerve pain from chemotherapy.

Methotrexate effectively controls eye inflammation in Japanese patients with non-infectious uveitis but requires careful monitoring for side effects.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Overexpression of SSAT causes hair loss and skin issues, but reducing putrescine can help.

RTA 408 cream protects mice from radiation skin damage.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Topical sulfonylurea may reduce excessive hair growth caused by certain medications.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Methotrexate plus prednisolone had the fewest serious side effects.